Terms: = Colorectal cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Staging
23 results:
1. Calcium-Sensing Receptor Expression in Breast cancer.
Busic-Pavlek I; Dumic-Cule I; Kovacevic L; Milosevic M; Delimar P; Korsa L; Marusic Z; Prutki M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511437
[TBL] [Abstract] [Full Text] [Related]
2. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
[TBL] [Abstract] [Full Text] [Related]
3. Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.
Crutcher MM; Snook AE; Waldman SA
Expert Rev Clin Pharmacol; 2022 Nov; 15(11):1317-1326. PubMed ID: 36259230
[TBL] [Abstract] [Full Text] [Related]
4. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; Sanchez-Vega F; Chatila WK; De La Torre SA; Patel A; Janjigian YY; Maron S; Ku GY; Tang LH; Hechtman J; Shah PM; Wu AJ; Jones DR; Molena D; Solit DB; Schultz N; Berger MF
Clin Cancer Res; 2021 Jun; 27(12):3491-3498. PubMed ID: 33795256
[TBL] [Abstract] [Full Text] [Related]
5. Colon cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Farkas L; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Johung KL; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Gurski LA
J Natl Compr Canc Netw; 2021 Mar; 19(3):329-359. PubMed ID: 33724754
[TBL] [Abstract] [Full Text] [Related]
6. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
[TBL] [Abstract] [Full Text] [Related]
7. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract] [Full Text] [Related]
8. her2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer.
Kwon MJ; Soh JS; Lim SW; Kang HS; Lim H
Pathol Res Pract; 2019 May; 215(5):910-917. PubMed ID: 30772061
[TBL] [Abstract] [Full Text] [Related]
9. [Molecular phenotypes of colorectal cancer is critical in clinical individual treatment].
Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):994-7. PubMed ID: 26499143
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Significance of Substaging and her2 Expression in Papillary Nonmuscle Invasive Urothelial cancers of the Urinary Bladder.
Lim SD; Cho YM; Choi GS; Park HK; Paick SH; Kim WY; Kim SN; Yoon G
J Korean Med Sci; 2015 Aug; 30(8):1068-77. PubMed ID: 26240484
[TBL] [Abstract] [Full Text] [Related]
11. Expression of her-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract] [Full Text] [Related]
12. Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: association with response to neoadjuvant therapy and prognosis.
Meng X; Wang R; Huang Z; Zhang J; Feng R; Xu X; Zhu K; Dou X; Chen D; Yu J
Cancer Sci; 2014 Jul; 105(7):818-24. PubMed ID: 24730770
[TBL] [Abstract] [Full Text] [Related]
13. Association of human epidermal growth factor receptor-2 expression and clinicopathological findings in patients with colorectal cancer.
Karaca H; Deniz K; Berk V; Inanc M; Ozkan M
Asian Pac J Cancer Prev; 2012; 13(12):6221-5. PubMed ID: 23464435
[TBL] [Abstract] [Full Text] [Related]
14. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
15. β-catenin and her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.
Drebber U; Madeja M; Odenthal M; Wedemeyer I; Mönig SP; Brabender J; Bollschweiler E; Hölscher AH; Schneider PM; Dienes HP; Vallböhmer D
Int J Colorectal Dis; 2011 Sep; 26(9):1127-34. PubMed ID: 21538055
[TBL] [Abstract] [Full Text] [Related]
16. Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin alphaV expression.
Chen JS; Hsu YM; Chen CC; Chen LL; Lee CC; Huang TS
J Biol Chem; 2010 Aug; 285(33):25458-66. PubMed ID: 20558745
[TBL] [Abstract] [Full Text] [Related]
17. [Correlations of c-erb-B2, EGFR, and TGF-alpha expression to recurrence of Dukes'A and B colorectal carcinoma].
Liang JL; Wan DS; Pan ZZ; Zhou ZW
Ai Zheng; 2007 Jun; 26(6):647-51. PubMed ID: 17562274
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.
Jesus EC; Matos D; Artigiani R; Waitzberg AF; Goldenberg A; Saad SS
Acta Cir Bras; 2005; 20(6):422-7. PubMed ID: 16302076
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
Hornick JL; Lauwers GY; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
[TBL] [Abstract] [Full Text] [Related]
20. K-RAS point mutation, and amplification of C-MYC and C-erbb2 in colon adenocarcinoma.
Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
[TBL] [Abstract] [Full Text] [Related]
[Next]
